Lv4
570 积分 2023-11-29 加入
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
1个月前
已完结
Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial
1个月前
已完结
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic Breast Cancer
1个月前
已完结
Combination of Baricitinib and Phototherapy in Adults With Active Vitiligo
1个月前
已完结
Safety and Monitoring of the Treatment with Disease-Modifying Therapies (DMTs) for Multiple Sclerosis (MS)
7个月前
已完结
儿童神经肌肉病的疾病修正治疗
8个月前
已完结
Phlegmonous gastritis: Review of the pathophysiology
9个月前
已关闭
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
9个月前
已完结
Diagnosis and treatment of chronic urticaria: current status and future prospects
9个月前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
9个月前
已完结
皖公网安备34019202002308
